Chitosan is the polymer of choice for delivery of the active moieties to the colon due to its
cationic nature that enables strong mucosal attachment. Chitosan is explored for …

Biologics have transformed the treatment of immune-mediated inflammatory diseases such
as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). Biosimilars—biologic …

The human body is a natural habitat for a multitude of microorganisms, with bacteria being
the major constituent of the microbiota. These bacteria colonize discrete anatomical …

Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis and
manifests as a complex and dysregulated immune response. To date, there is no cure for …

Inflammatory bowel disease (IBD) is a chronic multifactorial disease that affects the
gastrointestinal tract and results from an aberrant immune response toward luminal antigens …

What is known and objective The application of biologics to treat inflammatory bowel
disease (IBD), including Crohn's disease and ulcerative colitis, is well established. Our aim …

The etiopathogenesis of Inflammatory bowel disease (IBD) is a result of a complex
interaction between host immune response, the gut microbiome and environmental factors …

The dense innervation of the gastro-intestinal tract with neuronal networks, which are in
close proximity to immune cells, implies a pivotal role of neurons in modulating immune …

Prior to the biologic era, the medical management of patients with inflammatory bowel
disease (IBD) was dominated by the use of aminosalicylates, corticosteroids, and …

Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's
disease (CD), is characterized by persistent and recurrent gastrointestinal inflammation …